Navidea Biopharmaceuticals

YTD

ALL

Why Robinhood?

You can watch NAVB and buy or sell other stocks, ETFs, and their options commission-free!

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate.

CEO

Michael S. Rosol, PhD

CEOMichael S. Rosol, PhD

Employees

—

Employees—

Headquarters

Columbus, Ohio

HeadquartersColumbus, Ohio

Founded

1983

Founded1983

Employees

—

Employees—

NAVB Key Statistics

Market cap

100.00

Market cap100.00

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

3.06K

Average volume3.06K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.05

52 Week high$0.05

52 Week low

—

52 Week low—

Stock Snapshot

As of today, Navidea Biopharmaceuticals(NAVB) shares are valued at $1.61. The company's market cap stands at 100.

On 2026-04-01, Navidea Biopharmaceuticals(NAVB) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Navidea Biopharmaceuticals(NAVB) stock has reached 0, versus its average volume of 3.06K.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.